Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction

Kawahara, Eigo; Senpuku, Kota; Kawaguchi, Yoshino; Yamamoto, Shinya; Yasuda, Koubun; Kuroda, Etsushi; Ouji-Sageshima, Noriko; Ito, Toshihiro; Hirai, Toshiro; Shibata, Takehiko; Yoshioka, Yasuo

doi:https://doi.org/10.1038/S41541-024-00987-W

Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction

Kawahara, Eigo; Senpuku, Kota; Kawaguchi, Yoshino et al.

npj Vaccines, 2024, 9, 187

アクセス数:897件（2025-08-01 18:11 集計）

固定URL: https://hdl.handle.net/11094/98546

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
NpjVaccines_9_187	pdf	なし	4.12 MB	33	2024.12.02

Creative Commons : 表示

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction
著者	NRID 1000091004498 1000091004498 著者名 Kawahara, Eigo
	著者名 Senpuku, Kota
	著者名 Kawaguchi, Yoshino
	著者名 Yamamoto, Shinya
	NRID 1000050333539 1000050333539 著者名 Yasuda, Koubun
	NRID 1000010299604 1000010299604 著者名 Kuroda, Etsushi
	NRID 1000030398432 1000030398432 著者名 Ouji-Sageshima, Noriko
	NRID 1000000595712 1000000595712 著者名 Ito, Toshihiro
	NRID 1000000895815 1000000895815 ORCID 0000-0002-9212-1664 0000-0002-9212-1664 researchmap permalink toshiro.hirai toshiro.hirai Scopus Author ID 55628552543 55628552543 著者名 Hirai, Toshiro
	NRID 1000000739196 1000000739196 著者名 Shibata, Takehiko
	NRID 1000000392308 1000000392308 researchmap permalink read0076530 read0076530 Scopus Author ID 55502847200 55502847200 ORCID 0000-0002-7265-9221 0000-0002-7265-9221 著者名 Yoshioka, Yasuo
内容	Kawahara E., Senpuku K., Kawaguchi Y., et al. Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction. npj Vaccines 9, 187 (2024); https://doi.org/10.1038/S41541-024-00987-W.
抄録	The G protein expressed on the surface of respiratory syncytial virus (RSV) is important for adhesion to host cells and as a vaccine target antigen. The corresponding vaccines can effectively eliminate RSV. However, they exacerbate pulmonary immunopathology including eosinophilic infiltration in the lungs after an RSV challenge in animal models, raising concerns about enhanced respiratory disease (ERD); thus, approaches that mitigate these effects are urgently needed. Herein, we aimed to examine the mechanisms of G protein vaccine-induced ERD in mice, using recombinant G protein as a vaccine antigen. After the RSV challenge, G protein-vaccinated mice exhibited lung weight gain, lung tissue damage, and increased infiltration of eosinophils, neutrophils, and CD4+ T cells into the lungs. We set lung weight gain as the endpoint for ERD and examined the impact of each infiltrating cell on lung weight gain. We observed that CD4+ T cells, but not eosinophils or neutrophils, that infiltrate the lungs are responsible for lung weight gain. In addition, T helper 2 cell-mediated IL-13 induced mucin hypersecretion and lung weight gain. Mucin hypersecretion may contribute to weight gain in the lungs. In conclusion, our results indicate a novel mechanism of G protein vaccine-induced ERD via IL-13 and mucin hypersecretion, which could lead to the development of safe G protein vaccines and the elucidation of the causes of ERD associated with other vaccines.
出版者	Nature Research
収録物名	npj Vaccines
巻(号)	9
ページ	187
刊行年月	2024-10-12
言語	英語
ハンドルURL	https://hdl.handle.net/11094/98546
eISSN	20590105
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1038/S41541-024-00987-W
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCTERMS.bibliographicCitation	npj Vaccines. 2024, 9, p. 187
DC.title	Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction
DC.creator	Kawahara, Eigo
	Senpuku, Kota
	Kawaguchi, Yoshino
	Yamamoto, Shinya
	Yasuda, Koubun
	Kuroda, Etsushi
	Ouji-Sageshima, Noriko
	Ito, Toshihiro
	Hirai, Toshiro
	Shibata, Takehiko
	Yoshioka, Yasuo
DC.publisher	Nature Research
DC.language' scheme='DCTERMS.RFC1766	英語
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-10-12
DC.identifier	https://doi.org/10.1038/S41541-024-00987-W
DC.description	Kawahara E., Senpuku K., Kawaguchi Y., et al. Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction. npj Vaccines 9, 187 (2024); https://doi.org/10.1038/S41541-024-00987-W.
DCTERMS.abstract	The G protein expressed on the surface of respiratory syncytial virus (RSV) is important for adhesion to host cells and as a vaccine target antigen. The corresponding vaccines can effectively eliminate RSV. However, they exacerbate pulmonary immunopathology including eosinophilic infiltration in the lungs after an RSV challenge in animal models, raising concerns about enhanced respiratory disease (ERD); thus, approaches that mitigate these effects are urgently needed. Herein, we aimed to examine the mechanisms of G protein vaccine-induced ERD in mice, using recombinant G protein as a vaccine antigen. After the RSV challenge, G protein-vaccinated mice exhibited lung weight gain, lung tissue damage, and increased infiltration of eosinophils, neutrophils, and CD4+ T cells into the lungs. We set lung weight gain as the endpoint for ERD and examined the impact of each infiltrating cell on lung weight gain. We observed that CD4+ T cells, but not eosinophils or neutrophils, that infiltrate the lungs are responsible for lung weight gain. In addition, T helper 2 cell-mediated IL-13 induced mucin hypersecretion and lung weight gain. Mucin hypersecretion may contribute to weight gain in the lungs. In conclusion, our results indicate a novel mechanism of G protein vaccine-induced ERD via IL-13 and mucin hypersecretion, which could lead to the development of safe G protein vaccines and the elucidation of the causes of ERD associated with other vaccines.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	98546
citation_title	Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction
citation_author	Kawahara, Eigo
	Senpuku, Kota
	Kawaguchi, Yoshino
	Yamamoto, Shinya
	Yasuda, Koubun
	Kuroda, Etsushi
	Ouji-Sageshima, Noriko
	Ito, Toshihiro
	Hirai, Toshiro
	Shibata, Takehiko
	Yoshioka, Yasuo
citation_publisher	Nature Research
citation_language	英語
citation_date	2024-10-12
citation_journal_title	npj Vaccines
citation_volume	9
citation_firstpage	187
citation_doi	https://doi.org/10.1038/S41541-024-00987-W
citation_public_url	https://hdl.handle.net/11094/98546

Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction

閲覧可能ファイル

論文情報

論文詳細を表示